We can't find the internet
Attempting to reconnect
17673.2 PFLS-LS
Controlled drug delivery to the inner ear using ApidSOL/ApidCOR technology
Zusammenfassung
Controlled drug delivery to the inner ear using ApidSOL/ApidCOR technology
Weitere Texte
Abstract
Local drug delivery is an important topic for innovative treatments of inner ear diseases, such as hearing loss,|because of increased efficacy and decreased side effects. We propose to use Apidel proprietary drug delivery|technologies to optimize local inner ear administration of an established otoprotective drug (dexamethasone)|and an innovative and otoactive anti NOX3 siRNA. The results are expected to open important market|segments for Apidel.
Beteiligte
Thibault Mugnier
Wirtschaftspartner
thibault.mugnier@apidel.com
Apidel SA Thibault Mugnier Quai du Mont Blanc 29 1201 Genève GE CH
Pascal Senn
Kontaktperson
Pascal.Senn@hcuge.ch
Université de Genève Pascal Senn Rue Michel Servet 1 1211 Genève GE CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2016-03-31
- Enddatum
- 2018-03-31
- Bewilligte Gesamtkosten
- CHF 286442.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%